156 related articles for article (PubMed ID: 26214496)
1. High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?
Garcia-Hermoso D; Alanio A; Cabaret O; Olivi M; Foulet F; Cordonnier C; Costa JM; Bretagne S
Mycoses; 2015 Sep; 58(9):557-64. PubMed ID: 26214496
[TBL] [Abstract][Full Text] [Related]
2. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
4. A novel comprehensive set of fungal Real time PCR assays (fuPCR) for the detection of fungi in immunocompromised haematological patients-A pilot study.
Rahn S; Schuck A; Kondakci M; Haas R; Neuhausen N; Pfeffer K; Henrich B
Int J Med Microbiol; 2016 Dec; 306(8):611-623. PubMed ID: 27765533
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
[TBL] [Abstract][Full Text] [Related]
6. Identifying risk factors for exposure to culturable allergenic moulds in energy efficient homes by using highly specific monoclonal antibodies.
Sharpe RA; Cocq KL; Nikolaou V; Osborne NJ; Thornton CR
Environ Res; 2016 Jan; 144(Pt A):32-42. PubMed ID: 26546982
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
8. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
9. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.
Slavin M; van Hal S; Sorrell TC; Lee A; Marriott DJ; Daveson K; Kennedy K; Hajkowicz K; Halliday C; Athan E; Bak N; Cheong E; Heath CH; Orla Morrissey C; Kidd S; Beresford R; Blyth C; Korman TM; Owen Robinson J; Meyer W; Chen SC;
Clin Microbiol Infect; 2015 May; 21(5):490.e1-10. PubMed ID: 25677259
[TBL] [Abstract][Full Text] [Related]
10. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
[TBL] [Abstract][Full Text] [Related]
11. Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples.
White PL; Posso RB; Barnes RA
J Clin Microbiol; 2015 Jul; 53(7):2115-21. PubMed ID: 25903571
[TBL] [Abstract][Full Text] [Related]
12. Identification of Aspergillus species in oral tissue samples of patients with hematologic malignancies by in situ hybridization: a preliminary report.
Myoken Y; Sugata T; Mikami Y; Murayama SY; Fujita Y
J Oral Maxillofac Surg; 2008 Sep; 66(9):1905-12. PubMed ID: 18718399
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.
Rocchi S; Reboux G; Larosa F; Scherer E; Daguindeau E; Berceanu A; Deconinck E; Millon L; Bellanger AP
Indoor Air; 2014 Dec; 24(6):652-61. PubMed ID: 24621176
[TBL] [Abstract][Full Text] [Related]
14. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer.
Guinea J; Padilla C; Escribano P; Muñoz P; Padilla B; Gijón P; Bouza E
PLoS One; 2013; 8(4):e61545. PubMed ID: 23620764
[TBL] [Abstract][Full Text] [Related]
16. Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2.
Li Y; Gao L; Ding Y; Xu Y; Zhou M; Huang W; Jing Y; Li H; Wang L; Yu L
BMC Infect Dis; 2013 Jun; 13():255. PubMed ID: 23725402
[TBL] [Abstract][Full Text] [Related]
17. [Invasive fungal disease in patients from five hospitals in the Valparaíso region, Chile: 2004 to 2009].
Cruz Ch R; Piontelli L E
Rev Chilena Infectol; 2011 Apr; 28(2):123-9. PubMed ID: 21720691
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
[TBL] [Abstract][Full Text] [Related]
19. Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000-2008.
Hsiue HC; Ruan SY; Kuo YL; Huang YT; Hsueh PR
Clin Microbiol Infect; 2010 Aug; 16(8):1204-6. PubMed ID: 19886903
[TBL] [Abstract][Full Text] [Related]
20. Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.
Moura S; Cerqueira L; Almeida A
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1393-1403. PubMed ID: 29754210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
